convertible debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage
in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the person(s) under Section 258 of the Securities and Exchange
(DR). Convertible Securities: warrant or convertible debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage
Securities: warrant or convertible debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition
of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the person(s) under
percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the person(s) under Section 258 of the Securities and Exchange Act B.E.2535 . Preliminary version: incomplete
). Convertible Securities: warrant or convertible debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition
shareholders and directors of Modern Pharma Company Limited are not Executive Committee and shareholders including those with controlling power in the company. Therefore, it is not considered a connected